These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 10311607)

  • 21. Cost-utility analysis from a societal perspective.
    Johannesson M; O'Conor RM
    Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data.
    Reddy BP; Adams R; Walsh C; Barry M; Kind P
    Value Health; 2015 Sep; 18(6):841-5. PubMed ID: 26409612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joint Utility Estimators in Substance Use Disorders.
    Wittenberg E; Bray JW; Gebremariam A; Aden B; Nosyk B; Schackman BR
    Value Health; 2017 Mar; 20(3):458-465. PubMed ID: 28292491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories.
    Dale W; Basu A; Elstein A; Meltzer D
    Med Decis Making; 2008; 28(1):102-12. PubMed ID: 18057188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of health states after stroke: a systematic review of the literature.
    Post PN; Stiggelbout AM; Wakker PP
    Stroke; 2001 Jun; 32(6):1425-9. PubMed ID: 11387509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.
    Brazier J; Ara R; Azzabi I; Busschbach J; Chevrou-Séverac H; Crawford B; Cruz L; Karnon J; Lloyd A; Paisley S; Pickard AS
    Value Health; 2019 Mar; 22(3):267-275. PubMed ID: 30832964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs).
    Brunner HI; Maker D; Grundland B; Young NL; Blanchette V; Stain AM; Feldman BM
    Med Decis Making; 2003; 23(4):314-22. PubMed ID: 12926581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of assessment method and respondent population on utilities elicited for Gaucher disease.
    Clarke AE; Goldstein MK; Michelson D; Garber AM; Lenert LA
    Qual Life Res; 1997 Mar; 6(2):169-84. PubMed ID: 9161117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the performance of utility techniques in the absence of a gold standard.
    Giesler RB; Ashton CM; Brody B; Byrne MM; Cook K; Geraci JM; Hanita M; Souchek J; Wray NP
    Med Care; 1999 Jun; 37(6):580-8. PubMed ID: 10386570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.
    Gafni A
    Am J Manag Care; 1997 May; 3 Suppl():S21-32. PubMed ID: 10180338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferences for health states: a review of measurement methods.
    Torrance GW
    Mead Johnson Symp Perinat Dev Med; 1982; (20):37-45. PubMed ID: 6927515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic analysis in dermatology.
    Ellis CN; Reiter KL; Wheeler JR; Fendrick AM
    J Am Acad Dermatol; 2002 Feb; 46(2):271-83. PubMed ID: 11807441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why do multi-attribute utility instruments produce different utilities: the relative importance of the descriptive systems, scale and 'micro-utility' effects.
    Richardson J; Iezzi A; Khan MA
    Qual Life Res; 2015 Aug; 24(8):2045-53. PubMed ID: 25636660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, feasibility, and validity of a computer-based utility assessment tool for measuring asthma-specific health utilities in Malaysia using the standard gamble method.
    Yong YV; Shafie AA
    J Asthma; 2016 Oct; 53(8):835-42. PubMed ID: 27049693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring Health Utilities in Children and Adolescents: A Systematic Review of the Literature.
    Thorrington D; Eames K
    PLoS One; 2015; 10(8):e0135672. PubMed ID: 26275302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS.
    Schackman BR; Goldie SJ; Freedberg KA; Losina E; Brazier J; Weinstein MC
    Med Decis Making; 2002; 22(1):27-38. PubMed ID: 11833663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H
    Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness. How should it be determined?
    Beaves RG; Joseph H; Rohrer JE; Zeitler RR
    Eval Health Prof; 1988 Jun; 11(2):213-30. PubMed ID: 10312609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the economic foundations of CEA. Ladies and gentlemen, take your positions!
    Brouwer WB; Koopmanschap MA
    J Health Econ; 2000 Jul; 19(4):439-59. PubMed ID: 11010234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of utilities in economic evaluations of healthcare interventions-an introduction].
    Maetzel A
    Z Rheumatol; 2004 Oct; 63(5):380-4. PubMed ID: 15517298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.